This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Uncategorised Disease
  • /
  • The efficacy and safety of certolizumab pegol (CZP...
Journal

The efficacy and safety of certolizumab pegol (CZP) in the treatment of active rheumatoid arthritis (RA): a meta-analysis from nine randomized controlled trials.

Read time: 1 mins
Published:25th Mar 2020
Author: Zhou Q, Zhou Y, Chen H, Wang Z, Tang Z, Liu J.
Ref.:Int J Clin Exp Med. 2014 Nov 15;7(11):3870-80.
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest